Prevalence of Cannabis Use among Patients with Psychosis Reporting to the Psychiatry Ward, Saidu Group of Teaching Hospital
DOI:
https://doi.org/10.37762/jgmds.12-4.704Keywords:
Cannabis Use, Psychosis, Adolescents, Socioeconomic StatusAbstract
OBJECTIVES
To assess the prevalence and pattern of cannabis use among psychosis patients and its association with age group, gender, and socioeconomic status.
METHODOLOGY
This cross-sectional study was conducted at the Psychiatry Ward of Saidu Group of Teaching Hospital, Swat, using a consecutive sampling method on 183 patients. Pakistani male and female psychotic patients aged 18 and above with a history of cannabis use were included, while those with other psychiatric disorders, intellectual disabilities, neurodevelopmental disorders, incomplete records, or unwillingness to participate were excluded. Data on age, gender, and socioeconomic status were collected. Cannabis use frequency and duration were self-reported.
RESULTS
The mean age was 35.49 ± 9.14 years. There were 46 (25.14%) females and 137 (74.86%) males. Cannabis use was reported in 56 (30.6%) patients, with daily use by 48 (26.23%) and twice-daily use by 8 (4.37%) patients. Cannabis use was significantly associated with age group (p<0.001) and gender (p<0.001), but not with socioeconomic status (p=0.7). Daily or twice-daily use was more common among adolescents (50%) than adults (22%), with no females reporting daily or twice-daily use.
CONCLUSION
Cannabis use was prevalent among psychosis patients, with higher frequency observed in adolescents and males. Adolescents were more likely to report daily or twice-daily use of the substance. Frequent use was more common among individuals from low- and medium-socioeconomic backgrounds.
Downloads
Metrics
References
Nawaz R, Gul S, Amin R, Huma T, Al Mughairbi F. Overview of schizophrenia research and treatment in Pakistan. Heliyon. 2020;6(11):e05443. doi: https://doi.org/10.1016/j.heliyon.2020.e05545. PMID: 33294593 DOI: https://doi.org/10.1016/j.heliyon.2020.e05545
Rathod S, Javed A, Iqbal R, Al-Sudani A, Vaswani-Bye A, Haider I, et al. Results of a qualitative study of patient, carer and clinician views on the experience of caring for individuals with psychosis in Pakistan. Cogn Behav Ther. 2023;16:e17. https://doi.org/10.1017/S1754470X23000077. PMID: 36795550 DOI: https://doi.org/10.1017/S1754470X23000077
Groening JM, Denton E, Parvaiz R, Brunet DL, von Daniken A, Shi Y, et al. A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses. Psychiatry Res. 2024;331:115626. https://doi.org/10.1016/j.psychres.2023.115626. PMID: 37845182 DOI: https://doi.org/10.1016/j.psychres.2023.115626
Athanassiou M, Dumais A, Gnanhoue G, Abdel-Baki A, Jutras-Aswad D, Potvin S. A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders. Expert Rev Neurother. 2021;21(7):779-91. https://doi.org/10.1080/14737175.2021.1942845. PMID: 34139976 DOI: https://doi.org/10.1080/14737175.2021.1942845
Fiorentini A, Cantù F, Crisanti C, Cereda G, Oldani L, Brambilla P. Substance-induced psychoses: an updated literature review. Front Psychiatry. 2021;12:694863. https://doi.org/10.3389/fpsyt.2021.694863. PMID: 34335392 DOI: https://doi.org/10.3389/fpsyt.2021.694863
Robinson T, Ali MU, Easterbrook B, Hall W, Jutras-Aswad D, Fischer B. Risk thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis. Psychol Med. 2023;53(9):3858-68. https://doi.org/10.1017/S0033291722000502. PMID: 35153225 DOI: https://doi.org/10.1017/S0033291722000502
Matheson SL, Laurie M, Laurens KR. Substance use and psychotic-like experiences in young people: a systematic review and meta-analysis. Psychol Med. 2023;53(2):305-19. https://doi.org/10.1017/s0033291722003440. PMID: 36218202 DOI: https://doi.org/10.1017/S0033291722003440
Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull. 2016;42(5):1262-9. https://doi.org/10.1093/schbul/sbw003. PMID: 26884547 DOI: https://doi.org/10.1093/schbul/sbw003
Hasan SS, Shaikh A, Ochani RK, Ashrafi MM, Ansari ZN, Abbas SH, et al. Perception and practices regarding cannabis consumption in Karachi, Pakistan: a cross-sectional study. J Ethn Subst Abuse. 2021;20(3):471-89. https://doi.org/10.1080/15332640.2019.1667287. PMID: 31686536 DOI: https://doi.org/10.1080/15332640.2019.1667287
Crocker CE, Carter AJ, Emsley JG, Magee K, Atkinson P, Tibbo PG. When cannabis use goes wrong: mental health side effects of cannabis use that present to emergency services. Front Psychiatry. 2021;12:640222. doi: https://doi.org/10.3389/fpsyt.2021.640222. PMID: 33746933 DOI: https://doi.org/10.3389/fpsyt.2021.640222
Schoeler T, Baldwin JR, Martin E, Barkhuizen W, Pingault JB. Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research. Nat Ment Health. 2024;2(7):865-76. https://doi.org/10.1038/s44220-024-00261-x DOI: https://doi.org/10.1038/s44220-024-00261-x
Gage SH, Hickman M, Zammit S. Association between cannabis and psychosis: epidemiologic evidence. Biol Psychiatry. 2016;79(7):549-56. https://doi.org/10.1016/j.biopsych.2015.08.001. PMID: 26386405 DOI: https://doi.org/10.1016/j.biopsych.2015.08.001
Cantor N, Silverman M, Gaudreault A, Hutton B, Brown C, Elton-Marshall T, et al. The association between physical availability of cannabis retail outlets and frequent cannabis use and related health harms: a systematic review. Lancet Reg Health Am. 2024;32:143-9. https://doi.org/10.1016/j.lana.2024.100708. PMID: 39251210 DOI: https://doi.org/10.1016/j.lana.2024.100708
McDonald AJ, Kurdyak P, Rehm J, Roerecke M, Bondy SJ. Age-dependent association of cannabis use with risk of psychotic disorder. Psychol Med. 2024;54(11):2926-36. https://doi.org/10.1017/s0033291724000990. PMID: 38835676 DOI: https://doi.org/10.1017/S0033291724000990
Rodrigues RJ, Marques JM, Köfalvi A. Cannabis, endocannabinoids and brain development: from embryogenesis to adolescence. Cells. 2024;13(22):1875. https://doi.org/10.20944/preprints202410.1488.v1 DOI: https://doi.org/10.3390/cells13221875
Niloy N, Hediyal TA, Vichitra C, Sonali S, Chidambaram SB, Gorantla VR, et al. Effect of cannabis on memory consolidation, learning and retrieval and its current legal status in India: a review. Biomolecules. 2023;13(1):162. https://doi.org/10.3390/biom13010162. PMID: 36614393 DOI: https://doi.org/10.3390/biom13010162
Henneberger AK, Mushonga DR, Preston AM. Peer influence and adolescent substance use: a systematic review of dynamic social network research. Adolesc Res Rev. 2021;6(1):57-73. https://doi.org/10.1007/s40894-019-00130-0 DOI: https://doi.org/10.1007/s40894-019-00130-0
Prieto-Arenas L, Díaz I, Arenas MC. Gender differences in dual diagnoses associated with cannabis use: a review. Brain Sci. 2022;12(3):388. https://doi.org/10.3390/brainsci12030388. PMID: 35336279 DOI: https://doi.org/10.3390/brainsci12030388
Maccarrone M, Rapino C, Francavilla F, Barbonetti A. Cannabinoid signalling and effects of cannabis on the male reproductive system. Nat Rev Urol. 2021;18(1):19-32. https://doi.org/10.1038/s41585-020-00391-8. PMID: 33149112 DOI: https://doi.org/10.1038/s41585-020-00391-8
Oh H, Jang SK, Lee HS, Lee EB, Choi KH. Personality traits in individuals with the dual diagnosis of psychosis and substance use disorders: a comprehensive review and meta-analysis. J Dual Diagn. 2021;17(1):34-51. https://doi.org/10.1080/15504263.2020.1839827. PMID: 33089784 DOI: https://doi.org/10.1080/15504263.2020.1839827
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Hussain Ali, Sami Ul Haq, Jalil Ahmad Khan, Ashfaq Hussain, Saima Afsar, Khair Ul Inam, Afroz Ahmad
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
